Naropin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
63323-286 -
Package NDC
63323-286-27 -
Package NDC
63323-286-38 -
Application number
NDA020533 -
SPL ID
324532ac-4e54-4659-a1a2-9ade22a1ed3f -
SPL set ID
dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7 -
UNII
V910P86109 -
RxCUI
1734203 -
RxCUI
1734204 -
RxCUI
1734207 -
RxCUI
1734208 -
RxCUI
1734347 -
RxCUI
1734348 -
RxCUI
1734355 -
RxCUI
1734356 -
RxCUI
1734475 -
RxCUI
1734476 -
RxCUI
1734479 -
RxCUI
1734480 -
RxCUI
1734481 -
RxCUI
1734482 -
RxCUI
1734483 -
RxCUI
1734484
What the source publishes
- Labeler
- Fresenius Kabi USA, LLC
- Active ingredients
- ROPIVACAINE HYDROCHLORIDE
- Form
- INJECTION, SOLUTION
- Routes
- EPIDURAL, INFILTRATION, PERINEURAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Naropin",
"splId": "324532ac-4e54-4659-a1a2-9ade22a1ed3f",
"labels": [
{
"setId": "dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7"
}
],
"routes": [
"EPIDURAL",
"INFILTRATION",
"PERINEURAL"
],
"labeler": "Fresenius Kabi USA, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-27) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-286-41)",
"package_ndc": "63323-286-27",
"identifierStatus": "well-formed",
"marketing_start_date": "20090804"
},
{
"sample": false,
"description": "25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-38) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-286-43)",
"package_ndc": "63323-286-38",
"identifierStatus": "well-formed",
"marketing_start_date": "20090804"
}
],
"productId": "63323-286_324532ac-4e54-4659-a1a2-9ade22a1ed3f",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "63323-286",
"deaSchedule": null,
"genericName": "ROPIVACAINE HYDROCHLORIDE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ROPIVACAINE HYDROCHLORIDE",
"strength": "5 mg/mL"
}
],
"applicationNumber": "NDA020533",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20090804",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0363323286439",
"0363323285418",
"0363323286415",
"0363323285593",
"0363323285531"
],
"unii": [
"V910P86109"
],
"rxcui": [
"1734203",
"1734204",
"1734207",
"1734208",
"1734347",
"1734348",
"1734355",
"1734356",
"1734475",
"1734476",
"1734479",
"1734480",
"1734481",
"1734482",
"1734483",
"1734484"
],
"spl_set_id": [
"dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7"
],
"manufacturer_name": [
"Fresenius Kabi USA, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:63323-286_324532ac-4e54-4659-a1a2-9ade22a1ed3f"